Abstract
The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
| Bidragets oversatte titel | Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner |
|---|---|
| Originalsprog | Engelsk |
| IPC | A61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04 |
| Patentnummer | WO 2108/234301 A1 |
| Journaliseringsdato | 27/12/2018 |
| Land/Område | Danmark |
| Prioritetsdato | 19/06/2017 |
| Prioritetsnummer | EP20170176612 |
| Status | Udgivet - 27. dec. 2018 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver